| Medicine
of Cycling Members' Research |
|
| Douglas Bauer, MD |
| Areas of Expertise: Osteoporosis,
clinical biomarkers, thyroid dysfunction |
|
| Cycling Specific Research: |
|
| Non Cycling Research: |
| Estrogen metabolism and
breast cancer risk among postmenopausal women: a case-cohort study within
B~FIT, 2014 |
| The Calcium Supplement
Controversy: Now What? 2014 |
| Subclinical thyroid
dysfunction and functional capacity among elderly, 2014 |
| Natural history and risk
factors for adjacent vertebral fractures in the fracture intervention trial,
2013 |
| Frailty and risk for heart
failure in older adults: the health, aging, and body composition study, 2013 |
| Prevalence and correlates
of self-reported medication non-adherence among older adults with coronary
heart disease, diabetes mellitus, and/or hypertension, 2013 |
| Understanding and
Communicating the Benefits and Risks of Denosumab, Raloxifene, and
Teriparatide for the Treatment of Osteoporosis, 2013 |
| Clinical practice. Calcium
supplements and fracture prevention, 2013 |
| Racial
differences in antilipemic use and lipid control in high-risk older adults,
2013 |
| The burden of urinary
incontinence and urinary bother among elderly prostate cancer survivors, 2013 |
| High hip fracture risk in
men with severe aortic calcification - MrOS study, 2013 |
| Vertebral Augmentation vs
Nonsurgical Therapy: Improved Symptoms, Improved Survival, or Neither? 2013 |
| Changes in
cholesterol-lowering medications use over a decade in community-dwelling
older adults, 2013 |
| Modifiable risk factors
for pneumonia requiring hospitalization of community-dwelling older adults:
the Health, Aging, and Body Composition Study, 2013 |
| Normocalcemic
hyperparathyroidism and hypoparathyroidism in two community-based nonreferral
populations, 2013 |
| Genetic variation in
antioxidant enzymes, cigarette smoking, and longitudinal change in lung
function, 2013 |
| Epidemiology and long-term
clinical and biologic risk factors for pneumonia in community-dwelling older
Americans: analysis of three cohorts, 2013 |
| Subclinical hypothyroidism
and cardiovascular risk: how to end the controversy, 2013 |
| The burden of urinary
incontinence and urinary bother among elderly prostate cancer survivors, 2013 |
| BMD changes and predictors
of increased bone loss in postmenopausal women after a 5-year course of
alendronate, 2013 |
| Effects of antiresorptive
therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and
FREEDOM trials, 2013 |
| Low 25-hydroxyvitamin D
predicts the onset of mobility limitation and disability in
community-dwelling older adults: the Health ABC Study, 2013 |
| Prevalence and correlates
of self-reported medication non-adherence among older adults with coronary
heart disease, diabetes mellitus, and/or hypertension, 2013 |
| Obesity-related hormones
and endometrial cancer among postmenopausal women: a nested case-control
study within the B~FIT cohort, 2013 |
| Bisphosphonate therapy for
osteoporosis: benefits, risks, and drug holiday, 2013 |
| A prospective study of
thyroid function, bone loss, and fractures in older men: The MrOS study, 2013 |
| Mortality associated with
diabetes and cardiovascular disease in older women, 2012 |
| 25-hydroxyvitamin D status
and change in physical performance and strength in older adults: the Health,
Aging, and Body Composition Study, 2012 |
| Antihypertensive
drug class use and differential risk of urinary incontinence in
community-dwelling older women, 2012 |
| 25-Hydroxyvitamin
D, parathyroid hormone, and mortality in black and white older adults: the
health ABC study, 2012 |
| Statin use and
risk of prostate cancer in the prospective Osteoporotic Fractures in Men
(MrOS) Study, 2012 |
| Cigarette smoking
exposure and heart failure risk in older adults: the Health, Aging, and Body
Composition Study, 2012 |
| Subclinical
thyroid dysfunction and the risk of heart failure events: an individual
participant data analysis from 6 prospective cohorts, 2012 |
| Atypical femoral fracture
risk in patients treated with bisphosphonates, 2012 |
| Intensive
glycemic control is not associated with fractures or falls in the ACCORD
randomized trial, 2012 |
| Change in hip bone mineral
density and risk of subsequent fractures in older men, 2012 |
| Continuing bisphosphonate
treatment for osteoporosis--for whom and for how long? 2012 |
| Association of a
Modified Physiologic Index with mortality and incident disability: the
Health, Aging, and Body Composition study, 2012 |
| Relationship of changes in
total hip bone mineral density to vertebral and nonvertebral fracture risk in
women with postmenopausal osteoporosis treated with once-yearly zoledronic
acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT), 2012 |
| Subclinical
hyperthyroidism and the risk of coronary heart disease and mortality, 2012 |
| Bone mineral
density and fracture risk in older individuals with CKD, 2012 |
| Association of major and
minor ECG abnormalities with coronary heart disease events, 2012 |
| Framingham risk
score and alternatives for prediction of coronary heart disease in older
adults, 2012 |
| Association of
intact parathyroid hormone levels with subsequent hip BMD loss: the
Osteoporotic Fractures in Men (MrOS) Study, 2012 |
| Inflammatory
markers and the risk of hip fracture: the Women's Health Initiative, 2012 |
| Genetic variation
in antioxidant enzymes and lung function, 2012 |
| Clinical use of bone
turnover markers to monitor pharmacologic fracture prevention therapy, 2012 |
| Thyroid function
and mortality in older men: a prospective study, 2012 |
| Calciotropic
hormones and the risk of hip and nonspine fractures in older adults: the
Health ABC Study, 2012 |
| Thyroid function
and prevalent and incident metabolic syndrome in older adults: the Health,
Ageing and Body Composition Study, 2012 |
| Relationship
between bone mineral density changes with denosumab treatment and risk
reduction for vertebral and nonvertebral fractures, 2012 |
| Height loss in
older women: risk of hip fracture and mortality independent of vertebral
fractures, 2012 |
| The potential value of
monitoring bone turnover markers among women on alendronate, 2012 |
| Mortality
associated with diabetes and cardiovascular disease in older women, 2012 |
| Obesity increases
and physical activity decreases lower urinary tract symptom risk in older
men: the Osteoporotic Fractures in Men study, 2011 |
| Angiotensin-converting
enzyme inhibitor and statin use and incident mobility limitation in
community-dwelling older adults: the Health, Aging and Body Composition
study, 2011 |
| Hip fracture and
increased short-term but not long-term mortality in healthy older women, 2011 |
| Is age-related
decline in lean mass and physical function accelerated by obstructive lung
disease or smoking? 2011 |
| Effects of antiresorptive
treatment on nonvertebral fracture outcomes, 2011 |
| Serum
25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of
women: the Women's Health Initiative (WHI), 2011 |
| WHO absolute
fracture risk models (FRAX): do clinical risk factors improve fracture
prediction in older women without osteoporosis? 2011 |
| Novel methods to
evaluate fracture risk models, 2011 |
| Correlates and
prevalence of insufficient 25-hydroxyvitamin D status in black and white
older adults: the health, aging and body composition study, 2011 |
| Adipokines and
the risk of fracture in older adults, 2011 |
| Official Positions for
FRAX¨ Bone Mineral Density and FRAX¨ simplification from Joint Official
Positions Development Conference of the International Society for Clinical
Densitometry and International Osteoporosis Foundation on FRAX¨, 2011 |
| Effects of body
composition and adipose tissue distribution on respiratory function in
elderly men and women: the health, aging, and body composition study, 2011 |
| Proton pump
inhibitors and risk of fractures: a meta-analysis of 11 international
studies, 2011 |
| Association of
BMD and FRAX score with risk of fracture in older adults with type 2
diabetes, 2011 |
| Lung function and
risk for heart failure among older adults: the Health ABC Study, 2011 |
| The relationship
between bisphosphonate adherence and fracture: is it the behavior or the
medication? Results from the placebo arm of the fracture intervention trial,
2011 |
| Mortality risk in
older men associated with changes in weight, lean mass, and fat mass, 2011 |
| Arterial
stiffness and gait speed in older adults with and without peripheral arterial
disease, 2011 |
| Bone strength
measured by peripheral quantitative computed tomography and the risk of
nonvertebral fractures: the osteoporotic fractures in men (MrOS) study, 2011 |
| Consistency of bone
turnover marker and calcium responses to parathyroid hormone (1-84) therapy
in postmenopausal osteoporosis, 2011 |